Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype

F&S Science(2024)10.1016/j.xfss.2024.07.008Source: DataRank Database

Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype is a research paper published in F&S Science (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.28)OA: goldTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Austin G. Holmes ORCID,Jian‐Jun Wei ORCID,J. Brandon Parker ORCID,Debabrata Chakravarti ORCID,Priyanka Saini ORCID

Live enrichment

PubMed:39074663 PMC:PMC11588529 OpenAlex:https://openalex.org/W4401046912

NICHD

Grant: P50HD098580

NCI NIH HHS

Grant: R01 CA254367

Northwestern University

National Institutes of Health

FWCI

1.28

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttps://doi.org/10.1016/j.xfss.2024.07.008

GOLDhttps://doi.org/10.1016/j.xfss.2024.07.008

publisherhttps://doi.org/10.1016/j.xfss.2024.07.008

publisherhttps://api.elsevier.com/content/article/PII:S2666335X24000430?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666335X24000430?httpAccept=text/plain

Fields of Study

Uterine Myomas and TreatmentsGynecological conditions and treatmentsThyroid and Parathyroid SurgeryMedicine

MeSH Terms

FemaleHumansLeiomyomaMyometriumPhenotypeUterine NeoplasmsGene Expression Regulation, NeoplasticHMGA2 ProteinEpigenomics

Keywords

EpigenomicsUterine leiomyomaPhenotypeLeiomyomaHMGA2MyometriumBiologyCancer researchCell biologyUterusMedicinePathologyGeneGeneticsGene expressionDNA methylationmicroRNATranscriptomeFibroids

Sustainable Development Goals

SDG 0: Zero hunger

Engineered uterine primary myometrial cells with high-mobility group AT-hook 2 overexpression display a leiomyoma-like transcriptional and epigenomic phenotype

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)